Projects

IrsiCaixa collaborative researchers: Gustavo Rodríguez Esteban, Anna López Plana

External collaborative researchers: Rafael Villanueva, Laura Layos, Holger Heyn

The majority of SARS-CoV-2 infected individuals develop mild symptoms, but about 10-30% can develop a severe disease that requires hospitalization and, eventually, the admission into the intensive care unit (ICU). Although it is not clear which factors determine the development of this severe form of the disease, it has been postulated that a deregulated response by the body’s defenses against the infection might be behind the hyperinflammation and tissue damage observed in those patients.